Inotek Pharmaceuticals (United States)
Inotek Pharmaceuticals is a clinical-stage biopharmaceutical company based in Lexington, Massachusetts focused on the discovery, development and commercialization of novel therapies to treat glaucoma and other serious diseases of the eye. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Inotek Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
39%
Total
Publications
229
Total Open
Publications
89
Total
Citations
18K
Open Access
Percentage
39%
Total
Publications
229
Total Open
Publications
89
Total
Citations
18K
Breakdown
Publisher Open
22%
Both
9%
Other Platform Open
8%
Closed
61%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 18%
13
Hybrid 16%
11
No Guarantees 66%
47
Other Platform Open
Domain 74%
29
Institution 23%
9
Other Internet 8%
3
Public 3%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 26 |
Europe PMC | Domain | 22 |
Université de Lausanne - SERVAL | Institution | 2 |
University of Michigan - Deep Blue | Institution | 2 |
Figshare | Public | 2 |
CiteSeer X | Other Internet | 2 |
University of Toronto - TSpace | Institution | 1 |
University of North Texas - University of North Texas Digital Library | Other Internet | 1 |
University of Debrecen - University of Debrecen Electronic Archive | Institution | 1 |
Universitat Politècnica de València - Repositorio Institucional de la Universitat Politècnica | Institution | 1 |